Ketones are a backup source of energy for neurons. Now, exciting research reveals bigger news: Ketone esters help clear misfolded proteins in animal models of aging and Alzheimer’s.
Europe originally said Lecanemab (Brand-name Leqembi) was too risky to approve. Now they are recommending marketing it. Why the change of heart?
Japanese researchers develop a simple test for diagnosing Alzheimer's quickly, easily, with 83% accuracy.
The European Medicines Agency (EMA) recommended approving Leqembi® (generic lecanemab) for Alzheimer's. Originally skeptics, learn how the "Clarity AD" trial helped change their mind.
See Lady Liv, the first AI avatar born from real people’s lived experiences with dementia. Watch ‘Liv’ help those recently diagnosed, by answering questions only a peer who shares the experience of Alzheimer's would know.
Leqembi is an FDA-Approved Alzheimer's treatment. Hospital infusions take an hour each. 2025 is looking to see a new 15-second autoinjector version. For some, it should even work at home.
Why are some of the new anti-Alzheimer's antibodies better than others? With the FDA's approval of Lecanemab and Donanemab, it's worth staying on top of this topic's latest research.
The 2 newest Alzheimer's drugs, Leqembi (lecanemab) and Kisunla (donanemab) show promise, but many questions remain. Here are the three next ones.
A new Harvard study of 2,000 former NFL players shows one-third believe they have chronic traumatic encephalopathy (CTE), a neuropathological condition linked to repeated head trauma.
Right now, there are two FDA approved drugs to treat Alzheimer's itself. Find out why Remternetug may soon get approval as a third, even better treatment.
Kisunla, the newest Alzheimer's drug, is rapidly gaining acceptance around the world. Learn what it does and how to get it.
How do the new drugs Leqembi and Kisunla fight Alzheimer's? Surprisingly, increases in amyloid-beta protein levels can explain the slowing of Alzheimer's at least as well as the reduction in amyloid plaques.
